Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Co-occurring substance use disorder: The impact on treatment adherence in women with locally advanced cervical cancer.

Rubinsak LA, Terplan M, Martin CE, Fields EC, McGuire WP, Temkin SM.

Gynecol Oncol Rep. 2019 Mar 27;28:116-119. doi: 10.1016/j.gore.2019.03.016. eCollection 2019 May.

2.

Rates of and Factors Associated With Patient-reported Illicit Drug Use Screening by Health Care Professionals in the United States From 2013 to 2015.

Scialli AC, Terplan M.

J Addict Med. 2019 Apr 2. doi: 10.1097/ADM.0000000000000537. [Epub ahead of print]

PMID:
30946091
3.

Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists, and American Society of Addiction Medicine.

Ecker J, Abuhamad A, Hill W, Bailit J, Bateman BT, Berghella V, Blake-Lamb T, Guille C, Landau R, Minkoff H, Prabhu M, Rosenthal E, Terplan M, Wright TE, Yonkers KA.

Am J Obstet Gynecol. 2019 Mar 27. pii: S0002-9378(19)30500-9. doi: 10.1016/j.ajog.2019.03.022. [Epub ahead of print] No abstract available.

PMID:
30928567
4.

Screening for substance use in pregnancy and the newborn.

Polak K, Kelpin S, Terplan M.

Semin Fetal Neonatal Med. 2019 Apr;24(2):90-94. doi: 10.1016/j.siny.2019.01.007. Epub 2019 Feb 5. Review.

PMID:
30770326
5.

Best Practices for Pregnant Incarcerated Women With Opioid Use Disorder.

Peeler M, Fiscella K, Terplan M, Sufrin C.

J Correct Health Care. 2019 Jan;25(1):4-14. doi: 10.1177/1078345818819855. Epub 2019 Jan 7.

PMID:
30616487
6.

Contraceptive utilization among new exotic dancers: a cross-sectional study.

Terplan M, Martin CE, Nail J, Sherman SG.

Harm Reduct J. 2018 Nov 12;15(1):56. doi: 10.1186/s12954-018-0261-7.

7.

Pregnancy Intention, Risk Perception, and Contraceptive Use in Pregnant Women Who Use Drugs.

MacAfee LK, Dalton V, Terplan M.

J Addict Med. 2019 May/Jun;13(3):177-181. doi: 10.1097/ADM.0000000000000471.

PMID:
30394994
8.

Racial and Ethnic Disparities in the Incidence of Severe Maternal Morbidity in the United States, 2012-2015.

Admon LK, Winkelman TNA, Zivin K, Terplan M, Mhyre JM, Dalton VK.

Obstet Gynecol. 2018 Nov;132(5):1158-1166. doi: 10.1097/AOG.0000000000002937.

PMID:
30303912
9.

In Reply.

Terplan M, Laird HJ, Hand DJ, Wright TE, Premkumar A, Martin CE, Meyer MC, Jones HE, Krans EE.

Obstet Gynecol. 2018 Oct;132(4):1061-1062. doi: 10.1097/AOG.0000000000002885. No abstract available.

PMID:
30247340
10.

Pregnancy and Naltrexone Pharmacotherapy.

Jones CW, Terplan M.

Obstet Gynecol. 2018 Oct;132(4):923-925. doi: 10.1097/AOG.0000000000002864.

PMID:
30204703
11.

Fatal and Nonfatal Overdose Among Pregnant and Postpartum Women in Massachusetts.

Schiff DM, Nielsen T, Terplan M, Hood M, Bernson D, Diop H, Bharel M, Wilens TE, LaRochelle M, Walley AY, Land T.

Obstet Gynecol. 2018 Aug;132(2):466-474. doi: 10.1097/AOG.0000000000002734.

PMID:
29995730
12.

Pregnancy intention and opioid use disorder treatment retention in the MOTHER study.

Martin CE, Terplan M, O'Grady KE, Jones HE.

Am J Addict. 2018 Jul 11. doi: 10.1111/ajad.12735. [Epub ahead of print]

PMID:
29995313
13.

Characteristics of Pregnant Women Reporting Cannabis Use Disorder at Substance Use Treatment Entry.

Washio Y, Mark K, Terplan M.

J Addict Med. 2018 Sep/Oct;12(5):395-400. doi: 10.1097/ADM.0000000000000424.

PMID:
29864087
14.

Trends and disparities in receipt of pharmacotherapy among pregnant women in publically funded treatment programs for opioid use disorder in the United States.

Short VL, Hand DJ, MacAfee L, Abatemarco DJ, Terplan M.

J Subst Abuse Treat. 2018 Jun;89:67-74. doi: 10.1016/j.jsat.2018.04.003. Epub 2018 Apr 6.

PMID:
29706175
15.

Opioid Detoxification During Pregnancy: A Systematic Review.

Terplan M, Laird HJ, Hand DJ, Wright TE, Premkumar A, Martin CE, Meyer MC, Jones HE, Krans EE.

Obstet Gynecol. 2018 May;131(5):803-814. doi: 10.1097/AOG.0000000000002562.

16.

The Comprehensive Addiction and Recovery Act: Opioid Use Disorder and Midwifery Practice.

Murphy J, Goodman D, Johnson MC, Terplan M.

Obstet Gynecol. 2018 Mar;131(3):542-544. doi: 10.1097/AOG.0000000000002493.

PMID:
29420414
17.

Maternal Health in the United States.

Schiff DM, Patrick SW, Terplan M.

N Engl J Med. 2018 Feb 8;378(6):587. doi: 10.1056/NEJMc1715957. No abstract available.

PMID:
29419278
18.

A Pilot Randomized Controlled Trial of a Phone-based Intervention for Smoking Cessation and Relapse Prevention in the Postpartum Period.

Coleman-Cowger VH, Mark KS, Rosenberry ZR, Koszowski B, Terplan M.

J Addict Med. 2018 May/Jun;12(3):193-200. doi: 10.1097/ADM.0000000000000385.

19.

Risk of complication during surgical abortion in obese women.

Mark KS, Bragg B, Talaie T, Chawla K, Murphy L, Terplan M.

Am J Obstet Gynecol. 2018 Feb;218(2):238.e1-238.e5. doi: 10.1016/j.ajog.2017.10.018. Epub 2017 Oct 24.

PMID:
29074080
20.

Characteristics of pregnant women who reported alcohol use at admission to substance use treatment.

Washio Y, E Martin C, Goldstein ND, Terplan M.

J Subst Abuse Treat. 2017 Nov;82:82-86. doi: 10.1016/j.jsat.2017.09.010. Epub 2017 Sep 15.

PMID:
29021120
21.

Re: Neonatal Abstinence Syndrome and High School Performance.

Terplan M, Patrick S, Jansson LM.

Pediatrics. 2017 Jun;139(6). pii: e20170972A. doi: 10.1542/peds.2017-0972A. No abstract available.

22.

Women and the opioid crisis: historical context and public health solutions.

Terplan M.

Fertil Steril. 2017 Aug;108(2):195-199. doi: 10.1016/j.fertnstert.2017.06.007. Epub 2017 Jul 8. Review.

PMID:
28697909
23.

Cannabis and pregnancy: Maternal child health implications during a period of drug policy liberalization.

Mark K, Terplan M.

Prev Med. 2017 Nov;104:46-49. doi: 10.1016/j.ypmed.2017.05.012. Epub 2017 May 18.

PMID:
28528172
24.

Beyond the Treatment Box: Perspectives on the Federal Response to Opioid Use, Pregnancy, and Neonatal Abstinence Syndrome.

Terplan M.

J Addict Med. 2017 May/Jun;11(3):176-177. doi: 10.1097/ADM.0000000000000309.

PMID:
28406855
25.

Pregnant Women's Current and Intended Cannabis Use in Relation to Their Views Toward Legalization and Knowledge of Potential Harm.

Mark K, Gryczynski J, Axenfeld E, Schwartz RP, Terplan M.

J Addict Med. 2017 May/Jun;11(3):211-216. doi: 10.1097/ADM.0000000000000299.

PMID:
28252456
26.

Opioid detoxification during pregnancy needs to be grounded in addiction science.

Terplan M.

Am J Obstet Gynecol. 2017 Jun;216(6):623. doi: 10.1016/j.ajog.2017.02.030. Epub 2017 Feb 22. No abstract available.

PMID:
28235462
27.

Medically Assisted Withdrawal (Detoxification): Considering the Mother-Infant Dyad.

Jones HE, Terplan M, Meyer M.

J Addict Med. 2017 Mar/Apr;11(2):90-92. doi: 10.1097/ADM.0000000000000289.

PMID:
28079573
28.

Neonatal Abstinence Syndrome and Ethical Approaches to the Identification of Pregnant Women Who Use Drugs.

Terplan M, Minkoff H.

Obstet Gynecol. 2017 Jan;129(1):164-167. doi: 10.1097/AOG.0000000000001781.

PMID:
27926654
29.

The role of screening, brief intervention, and referral to treatment in the perinatal period.

Wright TE, Terplan M, Ondersma SJ, Boyce C, Yonkers K, Chang G, Creanga AA.

Am J Obstet Gynecol. 2016 Nov;215(5):539-547. doi: 10.1016/j.ajog.2016.06.038. Epub 2016 Jul 1. Review.

PMID:
27373599
30.

Detoxification from opiates during pregnancy: stressing the fetal brain.

McCarthy JJ, Terplan M.

Am J Obstet Gynecol. 2016 Nov;215(5):670.e1-670.e2. doi: 10.1016/j.ajog.2016.05.041. Epub 2016 Jun 2. No abstract available.

PMID:
27262972
31.

Opioid Use Disorder in Pregnancy: Health Policy and Practice in the Midst of an Epidemic.

Premkumar A, Terplan M.

Obstet Gynecol. 2016 Nov;128(5):1179. No abstract available.

PMID:
27776054
32.

Family Planning in Substance Use Disorder Treatment Centers: Opportunities and Challenges.

Robinowitz N, Muqueeth S, Scheibler J, Salisbury-Afshar E, Terplan M.

Subst Use Misuse. 2016 Sep 18;51(11):1477-83. doi: 10.1080/10826084.2016.1188944. Epub 2016 Jul 20.

PMID:
27440391
33.

Breast Implants, Self-Esteem, Quality of Life, and the Risk of Suicide.

Zuckerman DM, Kennedy CE, Terplan M.

Womens Health Issues. 2016 Jul-Aug;26(4):361-5. doi: 10.1016/j.whi.2016.03.002. Epub 2016 Apr 16. No abstract available.

PMID:
27094911
34.

Reproductive Health Needs Among Substance Use Disorder Treatment Clients.

Terplan M, Lawental M, Connah MB, Martin CE.

J Addict Med. 2016 Jan-Feb;10(1):20-5. doi: 10.1097/ADM.0000000000000175.

PMID:
26690290
35.

Factors Associated with Early Pregnancy Smoking Status Among Low-Income Smokers.

Coleman-Cowger VH, Koszowski B, Rosenberry ZR, Terplan M.

Matern Child Health J. 2016 May;20(5):1054-60. doi: 10.1007/s10995-015-1891-y.

36.

Prenatal Substance Use: Exploring Assumptions of Maternal Unfitness.

Terplan M, Kennedy-Hendricks A, Chisolm MS.

Subst Abuse. 2015 Sep 20;9(Suppl 2):1-4. doi: 10.4137/SART.S23328. eCollection 2015.

37.

Trends in Relative Survival for Ovarian Cancer From 1975-2011.

Temkin SM, Terplan M.

Obstet Gynecol. 2015 Oct;126(4):898. doi: 10.1097/AOG.0000000000001073. No abstract available.

PMID:
26393445
38.

Women-Centered Drug Treatment Services and Need in the United States, 2002-2009.

Terplan M, Longinaker N, Appel L.

Am J Public Health. 2015 Nov;105(11):e50-4. doi: 10.2105/AJPH.2015.302821. Epub 2015 Sep 17.

39.

In reply.

Cheng D, Salimi S, Terplan M, Chisolm MS.

Obstet Gynecol. 2015 Jun;125(6):1493-4. doi: 10.1097/AOG.0000000000000877. No abstract available.

40.

Knowledge, Attitudes, and Practice of Electronic Cigarette Use Among Pregnant Women.

Mark KS, Farquhar B, Chisolm MS, Coleman-Cowger VH, Terplan M.

J Addict Med. 2015 Jul-Aug;9(4):266-72. doi: 10.1097/ADM.0000000000000128.

PMID:
25974378
41.

Contraceptive use and method choice among women with opioid and other substance use disorders: A systematic review.

Terplan M, Hand DJ, Hutchinson M, Salisbury-Afshar E, Heil SH.

Prev Med. 2015 Nov;80:23-31. doi: 10.1016/j.ypmed.2015.04.008. Epub 2015 Apr 18. Review.

42.

Marijuana use and pregnancy: prevalence, associated characteristics, and birth outcomes.

Mark K, Desai A, Terplan M.

Arch Womens Ment Health. 2016 Feb;19(1):105-11. doi: 10.1007/s00737-015-0529-9. Epub 2015 Apr 19.

PMID:
25895138
43.

The Relationship Between Postpartum Depression and Perinatal Cigarette Smoking: An Analysis of PRAMS Data.

Salimi S, Terplan M, Cheng D, Chisolm MS.

J Subst Abuse Treat. 2015 Sep;56:34-8. doi: 10.1016/j.jsat.2015.03.004. Epub 2015 Mar 25.

44.

Psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions.

Terplan M, Ramanadhan S, Locke A, Longinaker N, Lui S.

Cochrane Database Syst Rev. 2015 Apr 2;(4):CD006037. doi: 10.1002/14651858.CD006037.pub3. Review.

45.

Geographic disparities amongst patients with gynecologic malignancies at an urban NCI-designated cancer center.

Temkin SM, Fleming SA, Amrane S, Schluterman N, Terplan M.

Gynecol Oncol. 2015 Jun;137(3):497-502. doi: 10.1016/j.ygyno.2015.03.010. Epub 2015 Mar 17.

PMID:
25795262
46.

Demystifying electronic cigarette use in pregnancy.

Farquhar B, Mark K, Terplan M, Chisolm MS.

J Addict Med. 2015 Mar-Apr;9(2):157-8. doi: 10.1097/ADM.0000000000000100.

PMID:
25622121
47.

Integrating screening, brief intervention and referral to treatment (SBIRT) into an abortion clinic: an exploratory study of acceptability.

Appel L, Ramanadhan S, Hladky K, Welsh C, Terplan M.

Contraception. 2015 Apr;91(4):350-2. doi: 10.1016/j.contraception.2015.01.006. Epub 2015 Jan 14.

PMID:
25596511
48.

Intimate partner violence and maternal cigarette smoking before and during pregnancy.

Cheng D, Salimi S, Terplan M, Chisolm MS.

Obstet Gynecol. 2015 Feb;125(2):356-62. doi: 10.1097/AOG.0000000000000609.

49.

Recent trends in treatment admissions for marijuana use during pregnancy.

Martin CE, Longinaker N, Mark K, Chisolm MS, Terplan M.

J Addict Med. 2015 Mar-Apr;9(2):99-104. doi: 10.1097/ADM.0000000000000095.

PMID:
25525944
50.

Alcohol-exposed pregnancy outcomes explained by social determinants of health.

Terplan M.

BJOG. 2015 Dec;122(13):1739. doi: 10.1111/1471-0528.13216. Epub 2014 Dec 4. No abstract available.

Supplemental Content

Loading ...
Support Center